Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients

Clinical Transplantation

Volumn 22, Issue 2, 2008, Pages 156-161

  Kedzierska, Karolina ^a   Kabat Koperska, Joanna ^a   Safranow, Krzysztof ^a   Domański, Maciej ^a   Gołembiewska, Edyta ^a   Bober, Joanna ^a   Bohatyrewicz, Romuald ^a   Ciechanowski, Kazimierz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

ACE I D gene; Angiotensinconverting enzyme; Erythrocytosis; Kidney transplantation; Polycythemia

Indexed keywords

ANGIOTENSIN II; AZATHIOPRINE; CIMETIDINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; CADAVER KIDNEY; CREATININE CLEARANCE; DNA POLYMORPHISM; ERYTHROCYTOSIS; ERYTHROPOIESIS; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HEMATOCRIT; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYCYTHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 41149142007     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00760.x     Document Type: Article

References (24)

1. Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int 2003: 63: 1187.
2. Yildiz A, Yazici H, Cine N et al. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. J Nephrol 2003: 16: 399.
3. Kazory A. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost 2004: 91: 646.
4. Gaciong Z, Koziak K, Jarzyło I et al. Erythropoietin production after kidney transplantation. Ann Transplant 1996: 1: 29.
5. Trivedi H, Lal SM. A prospective, randomised, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis. Ren Fail 2003: 25: 77.
6. Klingbeil AU, Muller HJ, Delles C et al. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients. Am J Hypertens 2000: 13: 1295.
7. Wang AY, Yu AW, Lam CW et al. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Dis 2002: 39: 600.
8. Kurella M, Butterly DW, Smith SR. Post transplant erythrocytosis in hypercalcemic renal transplant recipients. Am J Tranplant 2003: 3: 873.
9. Gupta M, Miller BA, Ashan N et al. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis. Transplantation 2000: 70: 1188.
10. Navis G, van der Kleij FGH, de Zeeuw D, de Jong PE. Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med 1999: 77: 781.
11. Costerousse O, Danilov S, Alhenc-Gelas F. Genetics of angiotensin I-converting enzyme. Clin Exp Hypertens 1997: 19: 659.
12. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990: 86: 1343.
13. Urabe A, Chiba S, Kosaka K, Takuku F. Response of uraemic bone marrow cells to erythropoietin in vitro. Scand J Haematol 1976: 17: 335.
14. Kessler M, Hestin D, Mayeux D et al. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study. Clin Nephrol 1996: 45: 83.
15. Remuzzi G. Routine renin-angiotensin system blockade in renal transplantation? Curr Opin Nephrol Hypertens 2002: 11: 1.
16. Micozkadioglu H, Colak T, Akcay A et al. Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis. Transplant Proc 2004: 36: 161.
17. Glicklich D, Kapoian T, Mian H et al. Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid percursors in patients with posttransplant erythrocytosis. Transplantation 1999: 15: 62.
18. Ryu SK, Cho EY, Park HY et al. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis. Yonsei Med J 2002: 43: 461.
19. Kuznetsova T, Staessen JA, Wang JG et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: A meta-analysis. J Hum Hypertens 2000: 14: 447.
20. Mazzali M, Filho GA. Use of aminophylline and enalapril in posttransplant polycythemia. Transplantation 1998: 15: 1461.
21. Kabat-Koperska J, Motyl W, Domański L et al. Methods of GFR determination - creatinine clearance after cimetidine administration in clinical practice. Acta Medica Austriaca 2004: 31: 51
22. Augustine JJ., Knauss TC, Schulak JA et al. Comparative effects of sirolimus and mycophenolate mofetil on erythropoesis in kidney transplant patients. Am J Transplant 2004: 4: 2001.
23. Nankivell BJ, Allen RD, O'Connell PJ, Chapman JR. Erythrocytosis after renal transplantation: Risk factors and relationship with GFR. Clin Transplant 1995: 9: 375.
24. Chien HC, Huang CC, Huang JY et al. Post-transplant erythrocytosis. Changgeng Yi Xue Za Zhi 1996: 19: 235.